Skip to main content

Advertisement

Log in

Effectiveness and Safety of the Combined Use of Tranexamic Acid: A Comparative Observational Study of 1909 Cases

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Background

Tranexamic acid (TA) use in lower‑limb arthroplasty has been valued in these surgeries high‑risk hemorrhagic due to its antifibrinolytic action. The objective of the present study was to determine the effectiveness of the combined intravenous (IV) and intraarticular (IA) administration of TA in lower‑limb arthroplasty.

Methods

We conduct a prospective observational study between January 1, 2014, and December 31, 2017, including all programmed lower‑limb arthroplasties. Patients were divided into four groups: no TA, 15 mg/kg IV TA, 3 g IA TA, and 15 mg/kg IV and 3 g IA. The effect on calculated total blood loss (milliliter of red blood cell [RBC]), hemoglobin, transfusion, and duration of hospitalization was studied after adjustment on age, American Society of Anesthesiologists, surgery, and postoperative curative anticoagulation. Complications related to TA administration were systematically reported.

Results

A total of 1909 patients were included – “no TA,” n = 184; “IV,” n = 1137; “IA,” n = 214; and “IV + IA,” n = 374. In the IV + IA group, a decrease in blood loss was observed compared to the no TA group (+ 220 ml 95% confidence interval [CI] [184; 255] of RBC P < 0.001) and in the IA group (+ 65 ml 95% CI [30; 99] of RBC P < 0.001). The length of hospital stay of the IV + IA group was shorter compared to the no TA group (hazard ratio [HR] 0.35, 95% CI [0.29; 0.43], P < 0.001) to the IA group (HR 0.57, 95% CI [0.48; 0.69], P < 0.001) and the IV group (HR 0.45, 95% CI [0.39; 0.50], P < 0.001). One case of deep vein thrombosis occurred in the group without TA.

Conclusion

Administration of combined TA appears effective and safe; further studies are needed in order to establish a consensual protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kremers, H. M., Larson, D. R., Crowson, C. S., Kremers, W. K., Washington, R. E., & Steiner, C. A., et al. (2015). Prevalence of total hip and knee replacement in the United States. The Journal of Bone and Joint Surgery, 97(17), 1386–1397

    Article  Google Scholar 

  2. Kurtz, S., Ong, K., Lau, E., Mowat, F., & Halpern, M. (2007). Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. The Journal of Bone and Joint Surgery, 89, 780–785.

    Article  Google Scholar 

  3. Pulido, L., Parvizi, J., Macgibeny, M., Sharkey, P. F., Purtill, J. J., Rothman, R. H., & Hozack, W. J., et al. (2008). In hospital complications after total joint arthroplasty. The Journal of Arthroplasty, 23, 139–145.

    Article  Google Scholar 

  4. Spahn, D. R. (2010). Anemia and patient blood management in hip and knee surgerya systematic review of the literature. Anesthesiology, 113, 482–495.

    Article  Google Scholar 

  5. Hart, A., Abou Khalil, J., Carli, A., Huk, O., Zukor, D., & Antoniou, J. (2014). Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. The Journal of Bone and Joint Surgery, 96, 1945–1951.

  6. Maxwell, M. J., & Wilson, M. J. (2006). Complications of blood transfusion. Continuing Education in Anaesthesia, Critical Care and Pain, 6, 225–229.

    Article  Google Scholar 

  7. Mannucci, P. M., & Levi, M. (2007). Prevention and treatment of major blood loss. New England Journal of Medicine, 356, 2301–2311.

    Article  CAS  Google Scholar 

  8. Khan, N., Troelsen, A., & Husted, H. (2015). Prevention of post-operative anaemia in hip and knee arthroplasty--a systematic review. Dan Med J, 62, A5170.

    PubMed  Google Scholar 

  9. Kagoma, Y. K., Crowther, M. A., Douketis, J., Bhandari, M., Eikelboom, J., & Lim, W. (2009). Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thrombosis Research, 123, 687–696.

    Article  CAS  Google Scholar 

  10. Zufferey, P., Merquiol, F., Laporte, S., Decousus, H., Mismetti, P., & Auboyer, C., et al. (2006). Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology, 105, 1034–1046.

    Article  Google Scholar 

  11. Alshryda, S., Sukeik, M., Sarda, P., Blenkinsopp, J., Haddad, F. S., & Mason, J. M. (2014). A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. The Bone and Joint Journal, 96-B, 1005–1015.

  12. Jain, N. P., Nisthane, P. P., & Shah, N. A. (2016). Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. The Journal of Arthroplasty, 31, 542–547.

    Article  Google Scholar 

  13. Song, E. K., Seon, J. K., Prakash, J., Seol, Y. J., Park, Y. J., & Jin, C. (2017). Combined administration of IV and topical tranexamic acid is not superior to either individually in primary navigated TKA. The Journal of Arthroplasty, 32, 37–42.

    Article  Google Scholar 

  14. Wu, Y. G., Zeng, Y., Yang, T. M., Si, H. B., Cao, F., & Shen, B. (2016). The efficacy and safety of combination of intravenous and topical tranexamic acid in revision hip arthroplasty: a randomized, controlled trial. The Journal of Arthroplasty, 31, 2548–2553.

    Article  Google Scholar 

  15. Yi, Z., Bin, S., Jing, Y., Zongke, Z., Pengde, K., & Fuxing, P. (2016). Tranexamic acid administration in primary total hip arthroplasty: a randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. The Journal of Bone and Joint Surgery, 98, 983–991.

    Article  Google Scholar 

  16. Nielsen, C. S., Jans, Ø., Ørsnes, T., Foss, N. B., Troelsen, A., & Husted, H. (2016). Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. The Journal of Bone And Joint Surgery, 98, 835.

    Article  Google Scholar 

  17. Karaaslan, F., Karaoğlu, S., Mermerkaya, M. U., & Baktir, A. (2015). Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous–intra-articular tranexamic acid administration. A prospective randomized controlled trial. The Knee, 22, 131–135.

    Article  Google Scholar 

  18. Lin, S. Y., Chen, C. H., Fu, Y. C., Huang, P. J., Chang, J. K., & Huang, H. T. (2015). The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. The Journal of Arthroplasty, 30, 776–780.

    Article  Google Scholar 

  19. Huang, Z., Ma, J., Shen, B., & Pei, F. (2014). Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. The Journal of Srthroplasty, 29, 2342–2346.

    Article  Google Scholar 

  20. Prakash, J., Seon, J. K., Song, E. K., Lee, D. H., Yang, H. Y., & Jin, C. (2018). Is combined administration of tranexamic acid better than both intravenous and topical regimes for total loss, hidden loss and post-operative swelling? A Randomized control trial. Indian Journal of Orthopaedics, 52, 117–123.

    PubMed  PubMed Central  Google Scholar 

  21. Adravanti, P., Di Salvo, E., Calafiore, G., Vasta, S., Ampollini, A., & Rosa, M. A. (2018). A prospective, randomized, comparative study of intravenous alone and combined intravenous and intraarticular administration of tranexamic acid in primary total knee replacement. Arthroplasty Today, 4, 85–88.

    Article  Google Scholar 

  22. Yang, L., Du, S., & Sun, Y. (2017). Is combined topical and intravenous tranexamic acid superior to single use of tranexamic acid in total joint arthroplasty? A meta-analysis from randomized controlled trials. Medicine (Baltimore), 96, e7609.

    Article  CAS  Google Scholar 

  23. Li, J. F., Li, H., Zhao, H., Wang, J., Liu, S., & Song, Y. (2017). Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. Journal of Orthopaedic Surgery and Research, 12, 22.

    Article  Google Scholar 

  24. Sun, Y., Jiang, C., & Li, Q. (2017). A systematic review and meta-analysis comparing combined intravenous and topical tranexamic acid with intravenous administration alone in THA. PLoS One, 12, e0186174.

    Article  Google Scholar 

  25. Haute Autorité de Santé (2018). Transfusions de Globules Rouges Homologues: produits, Indications, Alternatives. https://www.has-sante.fr/portail/jcms/c_1349939/fr/transfusionsde‑globules‑rouges‑homologues‑produits‑indications‑alternatives. Accessed 30 Apr 2018.

  26. Mercuriali, F., & Inghilleri, G. (1996). Proposal of an algorithm to help the choice of the best transfusion strategy. Current Medical Research and Opinion, 13, 465–478.

    Article  CAS  Google Scholar 

  27. Gibon, E., Courpied, J. P., & Hamadouche, M. (2013). Total joint replacement and blood loss: what is the best equation? International Orthopaedics, 37, 735–739.

    Article  Google Scholar 

  28. Andersson, L., Nilsoon, I. M., Colleen, S., Granstrand, J. B., & Melander, B. (1968). Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Annals of the New York Academy of Sciences, 146, 642–656.

    Article  CAS  Google Scholar 

  29. Karski, J. M., Dowd, N. P., Joiner, R., Carroll, J., Peniston, C., & Bailey, K., et al. (1998). The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 C). Journal of Cardiothoracic and Vascular Anesthesia, 12, 642–646.

    Article  CAS  Google Scholar 

  30. Wong, J., Abrishami, A., El Beheiry, H., Mahomed, N. N., Davey, J. R., & Gandhi, R., et al. (2010). Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. The Journal of Bone and Joint Surgery, 92, 2503–2513.

    Article  Google Scholar 

  31. Krauss, E. S., Cronin, M., Suratwala, S. J., Enker, P., Rosen, L., & Segal, A. (2017). Use of intravenous tranexamic acid improves early ambulation after total knee arthroplasty and anterior and posterior total hip arthroplasty. The American journal of orthopedics (Belle Mead NJ), 46, E314–E319.

    Google Scholar 

  32. Levy, J. H., Koster, A., Quinones, Q. J., Milling, T. J., & Key, N. S. (2018). Antifibrinolytic therapy and perioperative considerations. Anesthesiology, 128, 657–670.

    Article  CAS  Google Scholar 

  33. CRASH-2 trial collaborators, Shakur, H., Roberts, I., Bautista, R., Caballero, J., Coats, T., & Dewan, Y., et al. (2010). Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet, 376, 23–32.

  34. Henry, D. A., Carless, P. A., Moxey, A. J., O'Connell, D., Stokes, B. J., & Fergusson, D. A., et al. (2011). Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews, 1, CD001886.

Download references

Acknowledgements

We would like to thanks Mr. Robinson for his work on this article.

Funding

Nil.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles-Hervé Vacheron.

Ethics declarations

Conflict of interest

There are no conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 27 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vacheron, CH., Roy, P., Petit, P.Y. et al. Effectiveness and Safety of the Combined Use of Tranexamic Acid: A Comparative Observational Study of 1909 Cases. JOIO 54 (Suppl 1), 165–171 (2020). https://doi.org/10.1007/s43465-020-00071-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43465-020-00071-0

Keywords

Navigation